Company news
Medistim Asa (OSL:MEDI) news
Every Medistim Asa press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
MEDI: Record revenue and strong regional growth, with EBIT margin resilient despite tariff impacts
May 7, 2026
MEDI: Record revenue and EBIT margin in 2025, driven by global growth and innovation
February 27, 2026
Medistim is opening a direct sales office in Japan
February 3, 2026
Financial calendar
January 21, 2026
Management in Medistim ASA purchases shares
November 11, 2025
Medistim CCO Buys About NOK 535,000 Worth Of Co's Shares
November 10, 2025
MEDI: Record revenue and profit growth driven by Americas and imaging products; strong outlook ahead
October 24, 2025
Third quarter and year-to-date September results and financials for 2025 for Medistim ASA
October 17, 2025
MEDI: Record first-half growth driven by Americas, product mix, and margin expansion
August 20, 2025
First half and second quarter results and financials for 2025 for Medistim ASA
August 13, 2025
MEDI: Record revenue, margin expansion, and strategic hires set the stage for accelerated growth
May 9, 2025
The General Meeting in Medistim ASA decided a dividend of NOK 6.00 per share
May 8, 2025
Disclosure of voting rights in Medistim ASA
May 7, 2025
Medistim ASA - Share buyback program completed
April 24, 2025
Medistim ASA - Status on share buyback
April 16, 2025
Dividend proposal for 2024 Medistim ASA - Key information
April 15, 2025
Notice of Annual General Meeting in Medistim ASA
April 10, 2025
Board approval of the 2024 Financial statements for Medistim ASA
April 8, 2025
MEDI: Record revenue and stable profit in 2024, with strong AMERICAS growth and higher dividend
February 28, 2025
MEDI: Growth to NOK 1 billion targeted via INTUI software, innovation, and global clinical validation
December 16, 2024
MEDI: Americas drove Q3 growth, but imaging sales and Japan lagged; EBIT margin normalized at 24%
October 24, 2024
MEDI: Record sales and margin recovery driven by EMEA growth and direct market expansion
August 16, 2024